MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc.

$0.22

+0.00 +0.00% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 3:35 PM ET	0.22

Key Stats

Market Cap

30.54M

Avg Volume

1,681

EPS

-$0.03

52W High

$0.23

52W Low

$0.15

Div. Yield

0.0%

Valuation

P/B Ratio

1.79

P/S Ratio

1.98

EV/EBITDA

-9.83

EV/Revenue

1.95

Margins

Gross Margin 45.9%

Operating Margin (16.2%)

Net Margin (31.7%)

EBITDA Margin (19.8%)

Growth & Returns

Revenue Growth (YoY)

16.9%

Return on Equity

(18.2%)

Return on Assets

(7.4%)

Liquidity & Leverage

Current Ratio

6.89

Quick Ratio

3.17

Debt / Equity

0.28

Total Cash

7.16M

Total Debt

6.72M

About

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.